Partnering with eye care professionals to redefine what’s possible
At Tenpoint Therapeutics™, we’re rejuvenating vision for the aging eye. By understanding real-world needs and partnering with eye care professionals, we’re setting a new standard for presbyopia care.
Presbyopia is just the beginning
Presbyopiais a gradual loss of near visual acuity that typically begins around age 40 and significantly affects aging eyes and quality of life.1,2
We’re prioritizing:
Functional near visionto address real-world needs
Functional near visionto address real-world needs
Presbyopia affects people daily, making it difficult to read and manage work or social activities with just eyeglasses.2
Tenpoint Therapeutics™ is transforming the treatment landscape by confronting the unmet needs that millions of patients face in maintaining clear near vision as they age.
References:1. Katz JA, Karpecki PM, Dorca A, et al. Presbyopia—a review of current treatment options and emerging therapies. Clin Ophthalmol. 2021;15:2167-2178. 2. Mancil GL, Baily IL, Brookman KE, et al. Optometric clinical practice guideline:care of the patient with presbyopia. American Optometric Association; 2011. 3. Grzybowski A, Kapitanovaite L, Zemaitiene R. An updated systematic review of pharmacological treatments for presbyopia. Adv Ophthalmol Pract Res. 2024;4(4):220-225.
You are now leaving tenpointtherapeutics.com.
Are you sure you want to continue?